Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 25:93:154137.
doi: 10.1016/j.jelectrocard.2025.154137. Online ahead of print.

Electrocardiographic changes in transgender patients on gender-affirming hormone replacement therapy

Heather M Wang  1 , Meet S Shah  2 , Rafael E Toro-Manotas  3 , Shriya D Patel  3 , Fady Botros  3 , Diana G Finkel  4 , Christine M Gerula  2 , Emad F Aziz  2 ; FHRS
Affiliations
Free article

Electrocardiographic changes in transgender patients on gender-affirming hormone replacement therapy

Heather M Wang et al. J Electrocardiol. .
Free article

Abstract

Background: Differences in electrocardiogram (EKG) measurements exist between cisgender men and cisgender women, with men typically exhibiting shorter QTc intervals, longer QRS durations, and longer PR intervals. Limited data describe the effects of gender-affirming hormone replacement therapy (HRT) on EKG parameters in transgender individuals.

Objective: To evaluate electrocardiographic changes associated with HRT in transgender patients.

Methods: This retrospective, single-institution cohort study included transgender women and transgender men receiving estrogen or testosterone HRT with available pre- and post-HRT EKGs. Demographics and EKG measurements were collected and compared using paired t-tests and Wilcoxon signed-rank tests.

Results: Thirty patients met inclusion criteria (17 transgender women, 13 transgender men). Among transgender women, QRS duration decreased from a median of 96.0 (92.0-106.0) ms pre-HRT to 94.0 (86.0-100.0) ms post-HRT (p = 0.022). P-wave amplitude decreased in leads V3-V4 (p = 0.024, p = 0.037), and R-wave amplitude decreased in leads V4-V6 (p = 0.008, p = 0.025, p = 0.011, respectively) post-HRT. T-wave amplitude was lower in transgender women in lead V2 (p = 0.016) and higher in transgender men in leads V2-V3 post-HRT (p = 0.015, p = 0.024). Stratification by race showed an increase in heart rate in Black transgender women from 71.6 ± 12.8 to 84.9 ± 19.2 beats per minute post-HRT (p = 0.015). Similar differences in P-, R-, and T-wave amplitude were observed in Black transgender patients in select precordial leads.

Conclusion: HRT used for gender-affirming care is associated with electrocardiographic changes that trend toward patterns of the affirmed gender. Findings suggest baseline and follow-up EKGs should be standardized when initiating HRT. Larger studies are needed to clarify structural and arrhythmogenic implications.

Keywords: Electrocardiogram; Hormone replacement therapy; P-wave amplitude; QRS duration; R-wave amplitude; T-wave amplitude; Transgender.

PubMed Disclaimer

LinkOut - more resources